Trial intelligence / Profile preview

Esketamine vs Sufentanil for Postoperative Sleep Quality After Total Knee Arthroplasty in Elderly Patients

ChiCTR2500112981Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Dalian Medical University
Start
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of esketamine in Postoperative sleep disturbance (PSD) (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Sleep quality on the night after surgery. Started Nov 2025; status: recruiting.

02

Drugs

esketamine
03

Conditions

Postoperative sleep disturbance (PSD)

Beyond the preview

Go deeper on ChiCTR2500112981.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500112981.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call